Gates Dumps $150M Into COVID Research, Creating Massive Opportunity

The Bill & Melinda Gates Foundation have increased their contribution to COVID-19 research to the tune of $250 million, Reuters reports, with an additional $150 million donation. 

In addition to this most recent cash influx, funding research and development of testing equipment, drugs and vaccines, there seems to be no shortage of funding.

With Trump threatening to pull funding from WHO and new virus spikes across the globe, the current landscape for the pharmaceutical industry is in upheaval as new partners, like the Bill & Melinda Gates Foundation, continue to pour money into potential cures.

We’ve seen massive injections into companies like Novavax at “Warp Speed,” which recently received $1.4 BILLION in funding.

There is no doubt this will have an impact on the markets. With no cure in sight, all bets are off on who will come out ahead.

There are a host of potential frontrunners in the Race for the Cure… and James West’s meticulous research has led him to a few companies that could see their stock explode.

Remember Novavax? This was one of James’ early picks – since he listed it he has seen a 446.11% return on his investment!

But remember: this isn’t the only indicator – James’ set also set his sights on Inovio Pharmaceuticals… despite a measly $9 Million and funding from its partnership with Coalition for Epidemic Preparedness Innovations, he’s seen a 215.32% increase in his investment!

Throughout all this one thing is certain: funding appears to be ubiquitous heading into the future and there will be more opportunities to strike GOLD. Sign up now to find out his next pick before it explodes!